Our GLP-1 program features safe, effective, and FDA-approved treatments like WeGovy and Zepbound that are designed to help you lose weight and improve your overall health
Every CJC-1295 Ipamorelin protocol in our clinic starts with a contraindication review
Key drivers of clinical benefits Applying each of the differences in HbA1c, blood pressure, serum lipids, BMI and hypoglycemia in turn indicated that change in HbA1c was the biggest driver of clinical benefits for oral semaglutide versus empagliflozin, and change in BMI was the biggest driver of clinical benefits for oral semaglutide versus dulaglutide, with quality-adjusted life expectancy improvements of 0.09 and 0.02 QALYs, respectively, when only these differences between the treatment arms were applied
Add a brightening product if tolerated, such as vitamin C
Common interactions to discuss with your provider include: Metformin and semaglutide or metformin and tirzepatide : often combined for diabetes management alongside HRT